# DYNE THERAPEUTICS INC (DYN)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DYN/

- Reporting holders: 4
- Reported value: $48.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $30.3K | 1,882 | 0.0% | 12 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $13.8K | 859 | 0.0% | 7 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $3.9K | 243 | 0.0% | 6 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $822 | 51 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $48.9K |
| Q2 2026 | 248 | $4.5B |
| Q1 2026 | 229 | $3.4B |
| Q4 2025 | 232 | $3.6B |
| Q3 2025 | 208 | $2.0B |
| Q2 2025 | 198 | $1.2B |
| Q1 2025 | 205 | $1.3B |
| Q4 2024 | 203 | $2.6B |
| Q3 2024 | 204 | $4.1B |
| Q2 2024 | 193 | $4.0B |
| Q1 2024 | 170 | $2.8B |
| Q4 2023 | 125 | $997.1M |